This inventor holds 1 USPTO granted patent. Top assignee: Prothera Biologics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Richard Andrews in Pulmonary Disease Treatment
Introduction
Richard Andrews is an accomplished inventor based in Providence, RI (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary diseases. His innovative approach focuses on utilizing inter-alpha inhibitor proteins to address serious health conditions.
Latest Patents
Richard Andrews holds a patent for "Methods for treating pulmonary disease using inter-alpha inhibitor proteins." This invention features methods for treating or preventing pulmonary diseases, including acute respiratory distress syndrome (ARDS) and pneumonia. The methods involve administering inter-alpha inhibitor proteins (IαIps), such as inter-alpha inhibitor (IαI) and/or pre-alpha inhibitor (PαI), to subjects in need of treatment.
Career Highlights
Richard is currently associated with Prothera Biologics, Inc., where he continues to work on innovative solutions for pulmonary health. His dedication to research and development has positioned him as a key figure in the medical community.
Collaborations
Richard collaborates with notable colleagues, including Yow-Pin Lim and Denice Spero. Their combined expertise enhances the research efforts at Prothera Biologics, Inc.
Conclusion
Richard Andrews exemplifies the spirit of innovation in the medical field, particularly in the treatment of pulmonary diseases. His work not only contributes to scientific knowledge but also has the potential to improve patient outcomes significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile